▲ SURGE

Picocela Inc.

+30.1%
PCLANASDAQCommunication Services2026-06-04
8.03
Close
6.17
Prev Close
+30.15%
Change
9.8x
Vol Ratio

Why It Surged

No related news available.

Related News

Palvella targets 2H 2026 NDA filing while outlining >$1B peak U.S. sales potential for QTORIN rapamycin in microcystic lymphatic malformations (NASDAQ:PVLA)
Seekingalpha2026-05-08
PTC Therapeutics Withdraws Its New Drug Application Resubmission For Translarna For Duchenne Muscular Dystrophy Treatment After FDA Feedback - PTC Therapeutics (NASDAQ:PTCT)
Benzinga2026-02-12
FDA Approves Agilent Technologies' Expanded Use Of PD-L1 IHC 22C3 pharmDx, Code GE006, - Agilent Technolo
Benzinga2026-06-02
AbCellera Biologics (ABCL) Anticipates Major Developments in 202
Gurufocus2026-05-12
Pfizer’s New Phase 1 PF-07328948 Study Signals Ongoing Pipeline Investment
Tipranks2026-04-07

Technical Analysis

Signals
MACD BullishAbove SMA20
Key Indicators
62.62RSI (14)
4.72SMA 20
-2.72Bollinger Lower
12.15Bollinger Upper
4.72Bollinger Mid
1.59MACD
1.34MACD Signal
0.25MACD Hist
View CompanyBack to Surge Stocks
Picocela Inc. Surged +30.1% on 2026-06-04 — Analysis | Alpha Lenz